DemocratBill · H.Res. 1079· House(119-HRES-1079)

Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

Rep. Gottheimer
Age: 51 years
New Jersey
Introduced
2/25/2026
Last activity
2/25/2026 — Referred to the House Committee on Energy and Commerce.
Sponsored by
Josh Gottheimer
Cosponsors
Democrat - 0Republican - 1
Health
  1. Introduced
  2. In Committee

A House resolution is the House speaking for itself: stating a position, honouring someone, or setting its own rules. Adopting it is the whole process. Once the House agrees to it, it is officially the House's word; it is not a law, so the Senate and the President have no part in it.

What this bill would do

This resolution recognizes the significance of Charcot-Marie-Tooth disease (CMT) and its impact on people. It notes that CMT causes damage to peripheral nerves and can affect muscle control. The text states that an estimated 126,000 individuals in the United States have this disease. It also mentions that the specific gene causing CMT has not been identified and that federal funding for research actually decreased in 2022 compared to 2021. Finally, the resolution expresses a need for robust research funding through the National Institute of Neurological Disorders and Stroke.

Yes· 3 of 4

  • Would people with disabilities be better off under this?+5

    The resolution advocates for increased research funding that directly benefits those living with Charcot-Marie-Tooth disease.

  • Does this put more money into scientific research?+5

    The resolution advocates for increased federal investment into neurological research to combat CMT.

  • Does this put more money into medical research?+5

    The resolution calls for robust funding for research into Charcot-Marie-Tooth disease and other rare diseases.

The opposite

No question was scored the opposite.